Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schiff

Showing results (361-370 of 424) with videos related to

Pageof 43
Sort By:
Kidney International|August 1, 1990
Hepatitis C infection in two urban hemodialysis unitsL J Jeffers, G O Perez, M D de Medina, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1995
Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275C L Mendenhall, T E Moritz, G A Roselle, et al.
Blood|August 10, 1999
The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiologyS J Muñoz, H J Alter, Y Nakatsuji, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis BRobert P Perrillo, Ching-Lung Lai, Yun-Fan Liaw, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantationArie Regev, Enrique Molina, Rosana Moura, et al.
Gastroenterology|May 8, 2004
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled studyNezam H Afdhal, Douglas T Dieterich, Paul J Pockros, et al.
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling and response to endocrine therapy: the Royal Marsden ExperienceM Dowsett, S Johnston, L-A Martin, et al.
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Ophthalmic Genetics|October 7, 2025
A novel missense <i>TUBB4B</i> variant outside of the canonical hotspot is associated with cone-rod dystrophy and sensorineural hearing lossLauren Y Cao, Anna Duemler, Emily H Jung, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis CJ G McHutchison, K Patel, E R Schiff, et al.
Pageof 43

Showing results (361-370 of 424) with videos related to

Sort By:
Pageof 43
Kidney International|August 1, 1990
Hepatitis C infection in two urban hemodialysis unitsL J Jeffers, G O Perez, M D de Medina, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 1, 1995
Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275C L Mendenhall, T E Moritz, G A Roselle, et al.
Blood|August 10, 1999
The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiologyS J Muñoz, H J Alter, Y Nakatsuji, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis BRobert P Perrillo, Ching-Lung Lai, Yun-Fan Liaw, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantationArie Regev, Enrique Molina, Rosana Moura, et al.
Gastroenterology|May 8, 2004
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled studyNezam H Afdhal, Douglas T Dieterich, Paul J Pockros, et al.
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling and response to endocrine therapy: the Royal Marsden ExperienceM Dowsett, S Johnston, L-A Martin, et al.
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Ophthalmic Genetics|October 7, 2025
A novel missense <i>TUBB4B</i> variant outside of the canonical hotspot is associated with cone-rod dystrophy and sensorineural hearing lossLauren Y Cao, Anna Duemler, Emily H Jung, et al.
Alimentary Pharmacology & Therapeutics|December 18, 2007
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis CJ G McHutchison, K Patel, E R Schiff, et al.
Pageof 43